アスピリンによる抗血小板作用のＰｈａｒｍａｃｏｄｙｎａｍｉｃｓに関する情報学的研究　血小板中および血管内皮細胞中シクロオキシゲナーゼ阻害作用を考慮したＰｈａｒｍａｃｏｄｙｎａｍｉｃ　Ｍｏｄｅｌの構築

DOI NDLデジタルコレクション 被引用文献4件 参考文献43件

書誌事項

タイトル別名
  • Parmacodynamic Analysis of Antiplatelet Effect of Aspirin in the Literature. Modeling Based on Inhibition of Cyclooxygenase in the Platelet and the Vessel Wall Endothelium.
  • Modeling Based on Inhibition of Cyclooxygenase in the Platelet and the Vessel Wall Endothelium
  • 血小板中および血管内皮細胞中シクロオキシゲナーゼ阻害作用を考慮したPhamacodynamic Modelの構築

この論文をさがす

抄録

The pharmacokinetic-pharmacodynamic model for ascertaining the antiplatelet effect of aspirin was developed, considering the effect of aspirin on the metabolic turnover of cyclooxygenase in platelets and vessel wall endothelium. All date used for analysis were obtained from the literature. The pharmacodynamic parameters, K, K', ke and ke' as reaction rate constants of aspirin and cyclooxygenase in platelets and that in endothelium, and the turnover rate constants of cyclooxygenase in platelets and that in endothelium, respectively, were calculated based on the plasma aspirin concentration profile, the plasma thromboxane B2 concentration as the index of inhibition of cyclooxygenase in platelets and the reduction of prostacyclin production of venous tissue as the index of inhibition of cyclooxygenase in vessel wall endothelium.<BR>The values of K and K' were 3.21 and 0.97 ml·μg-1 · hr-1, respectively, demonstrating selectivity of aspirin to cyclooxygenase in platelets. The value of ke was 0.00630 hr-1, which was consistent with the platelet life span. The developed model could explain the long duration of antiplatelet activity of aspirin and may be useful for formulating a rational dosage regimen for effective antiplatelet therapy utilizing aspirin.

収録刊行物

  • 病院薬学

    病院薬学 22 (2), 133-141, 1996

    一般社団法人 日本医療薬学会

被引用文献 (4)*注記

もっと見る

参考文献 (43)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ